ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $199,000 | -42.3% | 25,957 | 0.0% | 0.04% | -33.9% |
| Q1 2019 | $345,000 | -14.6% | 25,957 | 0.0% | 0.06% | -26.3% |
| Q4 2018 | $404,000 | -20.8% | 25,957 | 0.0% | 0.08% | -7.3% |
| Q3 2018 | $510,000 | -31.5% | 25,957 | 0.0% | 0.08% | -28.7% |
| Q2 2018 | $745,000 | +21.3% | 25,957 | 0.0% | 0.12% | +13.9% |
| Q1 2018 | $614,000 | +10.2% | 25,957 | 0.0% | 0.10% | +18.8% |
| Q4 2017 | $557,000 | -9.3% | 25,957 | 0.0% | 0.08% | +3.7% |
| Q3 2017 | $614,000 | +211.7% | 25,957 | +159.6% | 0.08% | +164.5% |
| Q2 2017 | $197,000 | -6.2% | 10,000 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $210,000 | +11.7% | 10,000 | 0.0% | 0.03% | -8.8% |
| Q4 2016 | $188,000 | -10.0% | 10,000 | 0.0% | 0.03% | +3.0% |
| Q3 2016 | $209,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |